US Broker Ratings

BioNTech SE (BNTX) Stock Analysis: Promising 24.25% Upside Amid Robust Pipeline

BioNTech SE (NASDAQ: BNTX), the German biotechnology powerhouse, has been at the forefront of innovation with its development of immunotherapies targeting cancer and infectious diseases. With a market capitalization of..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Consensus and 21.85% Upside Potential

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, operates within the medical distribution industry. With a market capitalization of $35.37 billion, the company has established itself..

UnitedHealth Group (UNH) Stock Analysis: Exploring a Robust 6.96% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, offers a compelling proposition for investors seeking a blend of stability and growth. With a commanding market cap of..

Sanofi (SNY) Stock Analysis: Unveiling a 21% Potential Upside Amidst Market Challenges

Sanofi (SNY), a global powerhouse in the healthcare sector, is drawing significant attention from investors as it navigates a complex landscape with a potential 21.06% upside, according to analyst ratings...

AstraZeneca PLC (AZN) Stock Analysis: Riding the 6.96% Upside Potential with Strong Buy Ratings

AstraZeneca PLC (NASDAQ: AZN), a powerhouse in the healthcare sector and a leading player in the drug manufacturing industry, stands out with its impressive market capitalization of $251.5 billion. Headquartered..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a Solid 10.48% Potential Upside

For investors eyeing the healthcare sector, Thermo Fisher Scientific Inc (NYSE: TMO) stands as a formidable player with a market capitalization of $188.8 billion. As a leader in diagnostics and..

Becton, Dickinson (BDX) Stock Analysis: Navigating Growth and Stability with a 4.18% Upside Potential

Becton, Dickinson and Company (NYSE: BDX) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $57.23 billion,..

Pfizer, Inc. (PFE) Stock Analysis: An 11% Upside Potential Amid Strong Dividend Yield

Pfizer, Inc. (NYSE: PFE) is a healthcare titan that has been making waves in the drug manufacturing sector. With a market capitalization of $147.14 billion, the company is a prominent..

Eli Lilly and Company (LLY) Investor Outlook: Navigating a 24.72% Upside Potential

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to capture investor attention with its robust portfolio of pharmaceuticals and promising growth metrics. With a market..

Novo Nordisk A/S (NVO) Investor Outlook: Navigating Strong Growth and Potential Upside in Healthcare

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, has been a focal point for investors seeking robust growth opportunities in the pharmaceutical industry. Headquartered in Bagsvaerd, Denmark,..

Abbott Laboratories (ABT) Stock Analysis: Evaluating a Healthcare Giant’s 7.46% Potential Upside

Abbott Laboratories (NYSE: ABT), a titan in the healthcare sector, continues to capture investor interest with its robust product portfolio and promising market performance. With a market capitalization of $230.77..

Boston Scientific (BSX) Stock Analysis: Strong Buy Ratings and a Promising 16.93% Upside Potential

Boston Scientific Corporation (NYSE: BSX), a leader in the medical devices sector, continues to capture investor attention with a compelling market presence and robust growth metrics. With a market capitalization..

MeiraGTx Holdings plc (MGTX) Stock Analysis: A 248% Potential Upside with Promising Gene Therapy Innovations

In the bustling world of biotechnology, MeiraGTx Holdings plc (NASDAQ: MGTX) is carving out a niche with its cutting-edge gene therapy solutions. With a market cap of $631.51 million, this..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a Challenging Market with 36.94% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Boca Raton, Florida, the company specializes..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Exploring a 26.50% Potential Upside Amidst Healthcare Diagnostics Growth

Investors with a keen eye on the healthcare sector might find Myriad Genetics, Inc. (NASDAQ: MYGN) an intriguing prospect. Known for its innovative footprint in molecular diagnostics, Myriad Genetics is..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring the 44.85% Potential Upside for Investors

Emergent BioSolutions Inc. (NYSE: EBS), a key player in the healthcare sector specializing in preparedness and response solutions for public health threats, presents a compelling opportunity for investors with a..

Cel-Sci Corporation (CVM) Stock Report: Unpacking the 3,171% Potential Upside

For those with a keen interest in the biotechnology sector, Cel-Sci Corporation (NASDAQ: CVM) offers an intriguing narrative. This clinical-stage biotech company, valued at a market cap of $63.11 million,..

Personalis, Inc. (PSNL) Stock Analysis: Exploring a 51.56% Potential Upside in the Diagnostics & Research Sector

For investors with an eye on the healthcare sector, Personalis, Inc. (NASDAQ: PSNL) offers a fascinating prospect with its innovative approach in the diagnostics and research industry. Headquartered in Fremont,..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Unpacking a 140% Potential Upside in the Biotech Frontier

Sana Biotechnology, Inc. (NASDAQ: SANA) is capturing the attention of investors with its promising potential upside of 140.74%. This Seattle-based biotech company is carving out a niche in the healthcare..

Verve Therapeutics, Inc. (VERV) Stock Analysis: Unveiling a Potential 17.92% Upside in the Gene Editing Arena

Verve Therapeutics, Inc. (NASDAQ: VERV) is making waves in the biotechnology sector with its pioneering approach to treating cardiovascular diseases through gene editing. Based in Boston, Massachusetts, Verve is at..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds